These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 9604996

  • 1. Soluble TNF receptors release by polymorphonuclear cells and the serum levels in breast cancer patients before and after treatment.
    Jabłońska E, Kiluk M, Markiewicz W.
    Neoplasma; 1998; 45(1):17-20. PubMed ID: 9604996
    [Abstract] [Full Text] [Related]

  • 2. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 3. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.
    Jablonska E.
    Cytokine; 1998 Jul; 10(7):540-3. PubMed ID: 9702418
    [Abstract] [Full Text] [Related]

  • 4. Soluble IL-6 and TNF receptors release by polymorphonuclear and mononuclear cells in cancer patients.
    Jablonska E.
    Neoplasma; 1999 Jul; 46(1):35-9. PubMed ID: 10355532
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 6. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Jun; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 7. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
    Jabłońska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, Jabłoński J.
    Arch Immunol Ther Exp (Warsz); 2001 Jun; 49(1):63-9. PubMed ID: 11266093
    [Abstract] [Full Text] [Related]

  • 8. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková J, Jirsa M, Tesar V.
    Cas Lek Cesk; 1998 May 25; 137(11):341-5. PubMed ID: 9727208
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of tumor necrosis factor alpha and production of this cytokine by polymorphonuclear cells in breast cancer patients.
    Jabłońska E.
    Arch Immunol Ther Exp (Warsz); 1998 Aug 15; 46(2):93-6. PubMed ID: 9613706
    [Abstract] [Full Text] [Related]

  • 11. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 15; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 12. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer.
    Jabłońska E, Piotrowski L, Grabowska Z.
    Rocz Akad Med Bialymst; 1997 Jun 15; 42(1):99-106. PubMed ID: 9581469
    [Abstract] [Full Text] [Related]

  • 13. Changes in soluble IL-6 receptor and IL-6 production by polymorphonuclear cells and whole blood cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1998 Jun 15; 46(1):25-9. PubMed ID: 9510942
    [Abstract] [Full Text] [Related]

  • 14. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 Jun 15; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 15. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 15; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 16. TNFRs and IL-6R transmembrane receptors expression and release of their soluble forms by neutrophils and mononuclear cells from cancer patients.
    Jabłońska E, Jabioński J, Hołownia A, Iwaszkiewicz-Pawłowska A, Piotrowski L, Kiluk M, Grabowska SZ, Markiewicz W.
    Rocz Akad Med Bialymst; 2001 Jun 15; 46():113-25. PubMed ID: 11780554
    [Abstract] [Full Text] [Related]

  • 17. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 15; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 18. [Soluble TNF-alpha receptors].
    Jabłońska E.
    Postepy Hig Med Dosw; 1997 Jul 15; 51(5):567-75. PubMed ID: 9489455
    [Abstract] [Full Text] [Related]

  • 19. Release of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patients.
    Jablonska E.
    Cancer Lett; 1997 Oct 28; 119(1):79-85. PubMed ID: 18372525
    [Abstract] [Full Text] [Related]

  • 20. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
    Hübel K, Mansmann G, Schäfer H, Oberhäuser F, Diehl V, Engert A.
    Cytokine; 2000 Dec 28; 12(12):1797-800. PubMed ID: 11097751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.